Savara Inc. (SVRA)
NASDAQ·Healthcare·Biotechnology
$5.37
-1.01%
Mkt Cap $1.05B
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+86.4%
Consensus $10.00 vs current $5.37
NASDAQ·Healthcare·Biotechnology
$5.37
-1.01%
Mkt Cap $1.05B
No recent rating data.
Price Target (11 analysts)
$10.00
Range $10.00 – $10.00
+86.4%
Consensus $10.00 vs current $5.37